Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2019 Sep 15;200(6):791-792.
doi: 10.1164/rccm.201904-0898LE.

Reply to Yilmaz: Selection of Biologics for Type 2-High Asthma

Mary Clare McGregor  1 , James Krings  1 , Parameswaran Nair  2 , Mario Castro  1
Affiliations
Comment

Reply to Yilmaz: Selection of Biologics for Type 2-High Asthma

Mary Clare McGregor et al. Am J Respir Crit Care Med. .
No abstract available

PubMed Disclaimer

Comment on

  • Role of Biologics in Asthma.
    McGregor MC, Krings JG, Nair P, Castro M. McGregor MC, et al. Am J Respir Crit Care Med. 2019 Feb 15;199(4):433-445. doi: 10.1164/rccm.201810-1944CI. Am J Respir Crit Care Med. 2019. PMID: 30525902 Free PMC article. Review.
  • Selection of Biologics for Type 2-High Asthma.
    Yilmaz I. Yilmaz I. Am J Respir Crit Care Med. 2019 Sep 15;200(6):790-791. doi: 10.1164/rccm.201904-0763LE. Am J Respir Crit Care Med. 2019. PMID: 31106563 Free PMC article. No abstract available.

References

    1. McGregor MC, Krings JG, Nair P, Castro M. Role of biologics in asthma. Am J Respir Crit Care Med. 2019;199:433–445. - PMC - PubMed
    1. Casale TB, Luskin AT, Busse W, Zeiger RS, Trzaskoma B, Yang M, et al. Omalizumab effectiveness by biomarker status in patients with asthma: evidence from PROSPERO, a prospective real-world study. J Allergy Clin Immunol Pract. 2019;7:156–164, e1. - PubMed
    1. Mukherjee M, Kjarsgaard M, Radford K, Huang C, Leigh R, Dorscheid DR, et al. Omalizumab in patients with severe asthma and persistent sputum eosinophilia. Allergy Asthma Clin Immunol. 2019;15:21. - PMC - PubMed
    1. Global Initiative for Asthma (GINA) Difficult-to-treat & severe asthma in adolescent and adult patients, diagnosis and management: a GINA pocket guide for health professionalsVersion 2.0. 2019[accessed 2019 Apr 24]. Available from: www.ginasthma.org
    1. Hanania NA, Wenzel S, Rosén K, Hsieh HJ, Mosesova S, Choy DF, et al. Exploring the effects of omalizumab in allergic asthma: an analysis of biomarkers in the EXTRA study. Am J Respir Crit Care Med. 2013;187:804–811. - PubMed